News

Merck & Co and Avecia have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck

Arrayit Diagnostics, a majority-owned subsidiary of Arrayit Corporation, has reported its anticipated timeline for commercialisation of its microarray-based OvaDx pre-symptomatic ovarian cancer blood test. It is currently advancing

BioDelivery Sciences has reported that the primary efficacy endpoint was achieved in the Phase 2 pain study assessing the efficacy and safety of Bema Buprenorphine. The positive results

Abaxis has entered into the production animal diagnostics marketplace with its first product, a rapid Avian influenza antigen test. This is a USDA-licensed test for Avian influenza type

Aurobindo Pharma has received the final approval for Cetirizine Hydrochloride syrup 1mg/ml from the FDA. The approval of Cetirizine Hydrochloride syrup is under the prescription drug product category.

Mettler Toledo has presented roller compaction process optimisation using at-line particle characterisation, during the 2009 AAPS Annual Meeting, where the application of in situ particle characterisation was demonstrated

Galapagos has expanded its arthritis alliance with GlaxoSmithKline (GSK) to include additional drug discovery programs based on novel drug target, GT622. As per the terms of the extension,

Labopharm has initiated the regulatory approval process for its twice-daily Tramadol-Acetaminophen formulation in Europe under the decentralised procedure (DCP). According to DCP, Labopharm has submitted a marketing authorisation

Inverness Medical has presented the study published in Intensive Care Medicine, carried out in Vicenza, Italy. The study tested blood samples collected during admission to the ICU using